How do I calculate and dilute U200 rapid‑acting insulin (e.g., insulin lispro) to a U100 concentration for use in an Omnipod insulin pump in an adult with type 1 diabetes?

U200 Insulin in Omnipod: Not Recommended - Use U100 Only

Do not use U200 insulin lispro in an Omnipod insulin pump. U200 formulations are explicitly contraindicated for use in continuous subcutaneous insulin infusion (CSII) pumps, including the Omnipod system 1.

Why U200 Cannot Be Used in Pumps

• FDA labeling explicitly prohibits U200 insulin lispro (LYUMJEV U-200) administration via insulin pump 1
• Only U100 formulations are approved for CSII therapy - this includes insulin lispro U100, which can be safely used in compatible pump systems 1
• The concentrated U200 formulation is only available in prefilled pens to minimize dosing errors, and these pens cannot be used to fill pump reservoirs 2

Critical Safety Warning

Never transfer U200 insulin from a pen to a syringe or pump reservoir - this can result in severe overdosage and life-threatening hypoglycemia 1. The U200 formulation contains twice the concentration of insulin per milliliter compared to U100, meaning that drawing up what appears to be the correct volume would deliver double the intended insulin dose.

The Correct Approach for Omnipod Users

If Currently Using U200 Pens:

• Switch to U100 insulin lispro for pump use - the conversion is unit-for-unit (no dose adjustment needed when switching between U100 and U200 formulations of the same insulin) 1
• U100 insulin lispro is approved and stable for pump use for up to 9 days in the reservoir or according to pump manufacturer guidelines, whichever is shorter 1

Pump-Specific Requirements:

• Verify Omnipod compatibility with your specific insulin lispro U100 product by consulting the pump user manual 1
• Change reservoir every 9 days maximum or per manufacturer instructions 1
• Rotate infusion sites within the same region to reduce lipodystrophy risk 1
• Do not dilute or mix insulin when using CSII 1
• Avoid temperatures >98.6°F (37°C) for insulin in the pump reservoir 1

Why This Restriction Exists

The concentrated U200 formulations were developed specifically for patients requiring large insulin doses to reduce injection volume and improve adherence with pen injections 2. However:

• Pump reservoirs have limited capacity - using U200 would theoretically allow more insulin per reservoir, but this has not been studied or approved for safety 2
• Dosing accuracy concerns - pumps are calibrated for U100 insulin, and using U200 could lead to catastrophic dosing errors 1
• No stability data exists for U200 formulations in pump systems under the mechanical stress and temperature conditions of CSII 3

Alternative for High Insulin Requirements

If you require very high insulin doses and are considering U200 to reduce injection frequency:

• Continue using U100 in your Omnipod and change pods more frequently if needed 1
• Recent real-world data shows U200 can be used safely in some automated insulin delivery systems (specifically studied in Tandem t:slim X2), but this is not applicable to Omnipod and requires specific system compatibility 4
• Consider whether pump therapy remains optimal - patients requiring >200 units/day may benefit from discussing alternative delivery methods with their endocrinologist 2, 5

Bottom Line

There is no safe calculation or dilution method to use U200 insulin in an Omnipod. The only appropriate insulin concentration for Omnipod use is U100 1. Any attempt to use U200 in a pump system risks severe hypoglycemia from overdosage and is explicitly prohibited by FDA labeling.